Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Celestino Rodríguez,1 Trinidad García,1 Débora Areces,1,2 Estrella Fernández,1 Marcelino García-Noriega,3 Joan Carles Domingo41Department of Psychology, Faculty of Psychology, University of Oviedo, Oviedo, Spain; 2Child Education Program, Facult...

Full description

Saved in:
Bibliographic Details
Main Authors: Rodríguez C, García T, Areces D, Fernández E, García-Noriega M, Domingo JC
Format: article
Language:EN
Published: Dove Medical Press 2019
Subjects:
Omega 3
PUFAs
Eicosapentaenoic Acid (EPA)
docosahexaenoic acid (DHA)
Attention Deficit Hyperactivity Disorder (ADHD)
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Online Access:https://doaj.org/article/708e34b9af7940a7b045ab3b4c50a0cd
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/708e34b9af7940a7b045ab3b4c50a0cd

Similar Items